
Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
Oncology Today with Dr Neil Love
00:00
TAR‑200: Device and Clinical Use
Andrea Necchi describes TAR-200 (gemcitabine intravesical system), placement, continuous delivery, and rationale for use in NMIBC.
Play episode from 14:42
Transcript


